DXRX Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £5,251.54
Insider Selling (Last 12 Months): GBX 0

Diaceutics Insider Trading History Chart

This chart shows the insider buying and selling history at Diaceutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Diaceutics Share Price & Price History

Current Price: GBX 76
Price Change: Price Increase of +0.5 (0.66%)
As of 12/7/2022 09:32 AM ET

This chart shows the closing price history over time for DXRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Diaceutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/28/2022Nick RobertsInsiderBuy181GBX 1GBX 181
9/9/2022Nick RobertsInsiderBuy161GBX 93£149.73
4/6/2022Deborah DavisInsiderBuy5,000GBX 102£5,100
9/27/2021Deborah DavisInsiderBuy17,800GBX 111£19,758
6/17/2021Deborah DavisInsiderBuy20,000GBX 130£26,000
5/4/2021Philip Henry Hugh WhiteInsiderSell200,000GBX 123£246,000
See Full Table
Want To Catch The Next Hot Investing Trend (Look Inside?)
While millennials are trying to get rich in crypto Ponzi schemes- there's something happening that Wall Street is TOTALLY ignoring. And it's about to affect every American Citizen over 55...
And It Could Spark An Economic Boom For Investors

SEC Filings (Institutional Ownership Changes) for Diaceutics (LON:DXRX)

Diaceutics logo
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX patient journey that enables pharma customers to complete a longitudinal analysis of biomarker testing journeys of individual patients, which identifies opportunities for earlier testing and treatment; DXRX lab benchmarking that enables laboratories to gain competitive edge and compare key criteria to others in the industry providing metrics, such as disease, testing and methodology, market share, turnaround time, and laboratory leadership in these areas; DXRX test reimbursement, which enables pharma customers to engage with laboratories to fund the introduction of novel companion diagnostics, as well as reducing the lag time in test adoption; and DXRX test signal that delivers a real-time alert of a testing event, which allows pharma customers to identify therapeutically actionable patients in the previous weeks. In addition, it offers diagnostic landscape, planning, implementation, and tracking services; and consulting services for precision medicine diagnostics. Further, the company provides test standardization, test quality assessment, test report optimization, laboratory tech support, test access and reimbursement, laboratory training, and educational resources services. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Read More on Diaceutics

Today's Range

Now: GBX 76
Low: 76
High: 76

50 Day Range

MA: GBX 79.22
Low: 74.50
High: 91.12

52 Week Range

Now: GBX 76
Low: 74.50
High: 122.22

Volume

13 shs

Average Volume

44,063 shs

Market Capitalization

£64.20 million

P/E Ratio

8,200.00

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Diaceutics?

Diaceutics' top insider investors include:
  1. Deborah Davis (Insider)
  2. Nick Roberts (Insider)
  3. Philip Henry Hugh White (Insider)
Learn More about top insider investors at Diaceutics.
Want To Catch The Next Hot Investing Trend (Look Inside?)
While millennials are trying to get rich in crypto Ponzi schemes- there's something happening that Wall Street is TOTALLY ignoring. And it's about to affect every American Citizen over 55...
And It Could Spark An Economic Boom For Investors